AI in Washington's crosshairs but consensus far from certain
U.S. lawmakers are grappling with what guardrails to put around burgeoning artificial intelligence, but months after ChatGPT got Washington's attention, consensus is far from certain.
Interviews with a U.S. senator, congressional staffers, AI companies and interest groups show there are a number of options under discussion.
The debate will be in focus on Tuesday when OpenAI CEO Sam Altman makes his first appearance before a Senate panel.
Some proposals focus on AI that may put people's lives or livelihoods at risk, like in medicine and finance. Other possibilities include rules to ensure AI isn't used to discriminate or violate someone's civil rights.
Another debate is whether to regulate the developer of AI or the company that uses it to interact with consumers. And OpenAI, the startup behind the chatbot sensation ChatGPT, has discussed a standalone AI regulator.
It's uncertain which approaches will win out, but some in the business community, including IBM and the U.S. Chamber of Commerce, favor the approach that only regulates critical areas like medical diagnoses, which they call a risk-based approach.
If Congress decides new laws are necessary, the U.S. Chamber's AI Commission advocates that "risk be determined by impact to individuals," said Jordan Crenshaw of the Chamber's Technology Engagement Center. "A video recommendation may not pose as high of a risk as decisions made about health or finances."
Surging popularity of so-called generative AI, which uses data to create new content like ChatGPT's human-sounding prose, has sparked concern the fast-evolving technology could encourage cheating on exams, fuel misinformation and lead to a new generation of scams.
The AI hype has led to a flurry of meetings, including a White
Read more on tech.hindustantimes.com
